Antonio Ascione
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: A multicentre prospective study.
Journal: Journal of viral hepatitis
Published: May 23, 2021
Adipopenia Is the Rapid Screening Tool that Best Predicts Mortality in Patients with Decompensated Cirrhosis: Results of a Prospective Study.
Journal: Journal of gastrointestinal and liver diseases : JGLD
Published: February 06, 2021
Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience.
Journal: The American journal of gastroenterology
Published: July 31, 2020
Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study.
Journal: Drugs in context
Published: April 04, 2020
Rate of non-response to ursodeoxycholic acid in a large real-world cohort of primary biliary cholangitis patients in Italy.
Journal: Scandinavian journal of gastroenterology
Published: October 01, 2019
Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience.
Journal: Digestive diseases and sciences
Published: December 28, 2018
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.
Journal: Infection
Published: January 23, 2018
Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitis.
Journal: Infection
Published: November 02, 2017
Mortality from cirrhosis and hepatocellular carcinoma in Western Europe over the last 40 years.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: November 10, 2016
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study.
Journal: The lancet. Gastroenterology & hepatology
Published: September 18, 2016
Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life study.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: March 24, 2016
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience.
Journal: World journal of hepatology
Published: February 23, 2016
Last Updated: 09/26/2026